Haemonetics HAE Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's cash provided by (used in) operating activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's cash provided by (used in) operating activity, including discontinued operation?
- Haemonetics (HAE) reported cash provided by (used in) operating activity, including discontinued operation of $70.94M in Q1 2026.
- How has Haemonetics's cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- Haemonetics's cash provided by (used in) operating activity, including discontinued operation decreased by 39.1% year-over-year, from $116.56M to $70.94M.
- What is the long-term trend for Haemonetics's cash provided by (used in) operating activity, including discontinued operation?
- Over 4 years (2022 to 2026), Haemonetics's cash provided by (used in) operating activity, including discontinued operation has grown at a 14.2% compound annual growth rate (CAGR), from $172.26M to $293.22M.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.